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Abstract
In high-dimensional studies such as genome-wide association studies, the correction for multiple
testing in order to control total type I error results in decreased power to detect modest effects.
We present a new analytical approach based on the higher criticism statistic that allows
identification of the presence of modest effects. We apply our method to the genome-wide study of
rheumatoid arthritis provided in the Genetic Analysis Workshop 16 Problem 1 data set. There is
evidence for unknown bias in this study that could be explained by the presence of undetected
modest effects. We compared the asymptotic and empirical thresholds for the higher criticism
statistic. Using the asymptotic threshold we detected the presence of modest effects genome-wide.
We also detected modest effects using 90
th percentile of the empirical null distribution as a
threshold; however, there is no such evidence when the 95
th and 99
th percentiles were used. While
the higher criticism method suggests that there is some evidence for modest effects, interpreting
individual single-nucleotide polymorphisms with significant higher criticism statistics is of
undermined value. The goal of higher criticism is to alert the researcher that genetic effects
remain to be discovered and to promote the use of more targeted and powerful studies to detect
the remaining effects.
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Multiple genetic association studies of rheumatoid
arthritis (RA) have reported inconsistent results [1]. It
is hypothesized that these inconsistencies may be
explained by inability to detect modest effects due to
insufficient sample size [1]. In the case of high-
dimensional studies such as genome-wide association
studies, the correction for multiple testing in order to
control total type I error results in decreased power to
detect moderate effects. In a genome-wide study of RA
conducted by [2], the authors report that after account-
ing for known significant single-nucleotide polymorph-
isms (SNPs) and possible population stratification, there
is an inflation in the tail of the distribution of p-values
that could indicate unknown bias in the study. Another
explanation of this deviation from the expected distribu-
tion could be the presence of undetected, and therefore
unexplained, modest effects. It has been reported that
even for a larger data set that contains the provided data
as a subset, the power to detect a disease-associated allele
with population frequency of 0.2 and an odds ratio of
1.3 is only 13%, while for an odds ratio of 1.5 the power
is 90% [2]. Thus, there is a limited ability to detect
modest effects even with a larger sample size. We present
a new approach that allows the determination of
whether modest effects are present. Our technique is
based on the higher criticism (HC) statistic of Donoho
and Jin [3].
Materials and methods
Data
The data consist of 545,080 SNPs genotyped for 868
cases from the North American Rheumatoid Arthritis
Consortium (NARAC) and 1194 controls. This is a
subset of the Stage 1 data previously analyzed by Plenge
et al. [2], after removing duplicated and contaminated
samples. A detailed description of the complete data set
and collection procedures can be found in Plenge et al.
[2]. The data were offered as part of the Genetic Analysis
Workshop 16.
We performed quality-control filtering of SNPs following
the procedures in Plenge et al. [2]. We removed SNPs
with more than 5% missingness, minor allele frequen-
cies below 0.01, and based on Hardy-Weinberg equili-
brium (p <1 0
-5). Because no information on the ancestry
was provided, we assume that all related subjects and
subjects with non-Europian ancestry were removed [2].
Statistical Analysis
We applied the refined version of the HC statistic of
Donoho and Jin [3] to test whether all remaining SNPs
come from the null distribution and are not associated
with RA versus an alternative hypothesis that there is a
small number of moderate effects. The HC test can be
treated as a test of mixing proportion in a mixture
distribution with two components [3]: modest effects
with probability density function (pdf) f1 and null effects
have pdf f0. Then the pdf for the mixture distribution is
f = ε f1 +( 1 - ε)f2 The HC test for presence of modest
effects is equivalent to testing H0: ε =0 .
The HC test utilizes individual p-values and is imple-
mented as follows
[3,4]. Let p(1) <p(2) <...<p(n) be individual SNP test
p-values sorted in ascending order. Also let
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for a = 0.05 level test. We reject the null hypo-
thesis that there are no significant effects when
HC n n
* log log( ). > 2
We obtained a p-value for each SNP that passed quality-
control filtering using the test of genetic association
implemented in PLINK [5]. According to Plenge et al. [2]
there is evidence of population substructure in the given
sample, with chi-square statistics inflated by a factor of
1.43. We adopted the approach of Plenge et al. [2] based
on principal components to account for population
stratification. We used the eigenvectors of a covariance
matrix between all DNA samples as surrogates for
ancestry [6]. Approximately 120,000 autosomal SNPs
with pairwise correlation less than 0.3 were used to
calculate the covariance matrix. Following Plenge et al.
[2], we did not include SNPs on the short arms of
chromosomes 6 and 8 in this calculation. We recom-
puted the eigenvectors after removing seven outliers
identified by inspecting the eigenvectors associated with
the top ten eigenvalues. As in Plenge et al. [2], we chose
the top three vectors that were statistically significant
predictors of case-control status to correct for population
stratification and included them as covariates in a
logistic regression model in PLINK. We obtained the
inflation factor of all association results, excluding
results on the short arm of chromosome 6 (lGC =
1.035), which is similar to one in Plenge et al. [2].
The HC test evaluates evidence of modest effects that
could be present in the data in addition to the significant
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test genome-wide after removing known significant
effects, which were defined as regions identified in the
previous studies as associated with RA on a genome-wide
level. Excluded SNPs were from the extended MHC
region [1] from HIST1H2AA to K1FC1, the TRAF1-C5
region [2] extended to PHF19-C5 because of linkage
disequilibrium, and the PTPN22 region [1]. The base-
pair positions for excluded regions were identified using
hg16 map provided with the data. We recomputed the
inflation factor for the remaining SNPs and obtained
λGC
∗ = 1.030. We obtained p-values corresponding to
chi-square statistics from the logistic regression model
described above; these were also corrected for the
residual inflation by dividing by λGC
∗ .
We compared the use of the asymptotic threshold
for the HC statistic as in Cayon et al. [4], i.e.,
HC n n
* log log( ). > 2 , to the empirical threshold. One
thousand data sets from the null distribution were
generated by permuting case/control status while keep-
ing other variables constant. We applied the same
logistic model with principal components computed
for the original data as covariates and the same excluded
SNPs as in the analysis of non-permuted data. We
considered three options for the empirical threshold:
90
th,9 5
th,a n d9 9
th percentile of HCnull
∗ .
Results
Genome-wide analysis
There were 488,126 SNPs remaining after quality control
filtering and removing regions with previously identified
significant effects. Maximum HC was computed for
24,402 SNPs that satisfied 1 ≤ i ≤ 0.05n,a n dp(i) ≥ 1/n
conditions and was equal to 3.333 while the genome-
wide asymptotic threshold was 2.268. Figure 1 shows
HCn, i statistics for the region over which maximum HC
was computed. It also shows the asymptotic threshold.
These results indicate presence of modest effects on a
genome-wide level. Thus, after SNPs with known
significant effects have been removed there is still
evidence for association with RA that has not been
explained. The highest p-value for which HC exceeds the
threshold is 9.19 × 10
-4, while the maximum of HCn, i
corresponds to p =7 . 4 6×1 0
-6. There were 282 HCn, i
statistics exceeding the asymptotic threshold, indicating
modest effects.
Empirical threshold
The values of 90
th,9 5
th,a n d9 9
th percentiles of HCnull
∗
are 2.953, 3.591, and 5.259, respectively. Jin [4]
suggested calling the HC statistic significant if it exceeds
99% of generated HC statistics from the null distribu-
tion. However, inspection of HCnull
∗ statistics suggests
that this empirical threshold could be driven by a small
number of outliers. Therefore, the 90
th and 95
th
percentiles of HCnull
∗ could be more appropriate choices.
When 90
th percentile is selected as threshold, seven HC
statistics exceed the threshold, indicating the presence of
modest effects. The p-values corresponding to these
statistics range between 6.81 × 10
-6 and 6.21 × 10
-4.
There is no evidence of modest effects at the 95
th and
99
th percentile levels.
Discussion
The HC statistic using the asymptotic threshold indicates
the presence of modest effects on a genome-wide level.
However, this threshold is not a boundary for a
significance test, but rather a large-sample analytical
result that applies to any data set, and gives the
expectation of the HC statistic under the null hypothesis.
It gives a crude idea of what values of HC start to be
interesting, and displays the effect of the number of tests.
Using an asymptotic threshold in this application may
not be appropriate due to dependency between the
individuals. Asymptotic assumptions discussed else-
where [3,4] are not met in this study. We considered
three options for the empirical threshold; for one of
which provides evidence of modest effects, but not the
other two. Thus, the choice of a percentile of null
distribution to be used as a threshold has a direct effect
Figure 1
Higher criticism statistics HCn, i for 24,402 SNPs.
Horizontal lines from bottom to top: asymptotic threshold,
90% empirical threshold, 95% empirical threshold, 99%
empirical threshold.
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Additional study of an appropriate empirical null
distribution and empirical threshold is required.
The HC graph in Figure 1 demonstrates that there is no
direct correspondence between HCn, i statistics and
p-values in a sense that smaller p-values produce higher
HCn, I values. In fact, the maximum of HCn, i corresponds
to p =7 . 4 6×1 0
-6, which is not significant after correction
for multiple testing using Benjamini-Hochberg rule [7]:
pBH = 0.364. Thus, this effect is not significant enough to
be detected by traditional approaches, which supports
the usefulness of the HC statistic for detection of the
presence of modest effects in the context of multiple
hypothesis testing.
In addition, although the region where HCn, i statistics
exceed the asymptotic threshold does not include the
statistics corresponding to the smallest p-values, this is
the region of interest. The region of HCn, i statistics above
the threshold can be used to identify the range of
p-values that could contain modest effects because it
contains larger frequency of p-values in a specific range
than expected by chance [4]. On the other hand, the
region to the left that contains smaller p-values does not
have a higher frequency of p-values than expected by
chance. Therefore, the hypothesis is that the unidentified
modest effects could be found in the range of p-values
for which the HCn, i statistics exceed the threshold, while
the conventional approach of considering only most
extreme p- v a l u e su pt oac e r t a i nt h r e s h o l dm a yl e a dt o
missing modest effects. HC results could be used to alert
a researcher that there is another range of larger p-values
and smaller effect sizes that could be of interest and to
promote the use of more targeted and powerful studies
to detect the remaining genetic effects. Because the HC
test is a global test of the presence of modest effects,
caution should be exercised when trying to interpret
individual SNPs with p-values in the range of interest.
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